A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat

Low Pearson, Joseph Garcia, Foon Wu, Nidia Modesti, Jay Nelson, Richard Gaynor

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Regulation of human immunodeficiency virus (HIV) gene expression is dependent on specific regulatory region in the long terminal repeat. These regions include the enhancer, SP1, "TATA," and trans-activating (TAR) regions, In addition, viral regulatory proteins such as tat and rev are Important in regulating HIV gene expression. The mechanism of tat activation remains the subject of investigation, but effects at both transcriptional and posttranscriptional levels seem likely. Pervious mutagenesis of the tat protein revealed that the amino terminus, the cysteine-rich domain, and the basic domain were all required for complete tat activation. Mutants of other viral trans-acting regulatory proteins, including E1A, tax, and VM65, have been identified that were capable of antagonizing the activity of their corresponding wild-type proteins. We wished to determine whether mutants of the tat protein could be identified that exhibited a similar phenotype. One mutant (Δ) that truncated the basic domain of tat resulted in a transdominant phenotype inhibiting tat-induced gene expression of the HIV long terminal repeat but not other viral promoters. This tant exhibited its maximal phenotype in cotransfection expriments when present in an 8- to 30-fold molar excess over the wild-type tat gene. Trans-activation of the HIV long terminal repeat by Δtat was very defective at the DNA concentrations in these experiments. RNase protection analysis indicated t this mutant decreased tat-induced steady-state mRNA levels of the HIV long terminal repeat. Second-site mutations of the gene in either the amino terminus or cysteine region lnated the transdominant phenotype. In contrast to tat, which was localized predominantly to the nucleolus, Δtat was present in both the nucleus and cytoplasm, suggesting that it may bit tat function by preventing nucleolar localization. Trans-dominant mutants of tat may have a role in potentially inhibiting HIV gene expression.

Original languageEnglish (US)
Pages (from-to)5079-5083
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume87
Issue number13
StatePublished - 1990
Externally publishedYes

Fingerprint

tat Genes
HIV Long Terminal Repeat
tat Gene Products
Phenotype
Gene Expression
HIV
Cysteine
Viral Regulatory and Accessory Proteins
Terminal Repeat Sequences
Nucleic Acid Regulatory Sequences
Mutant Proteins
Ribonucleases
Mutagenesis
Cytoplasm
Proteins
Messenger RNA
Mutation
DNA
Genes

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat. / Pearson, Low; Garcia, Joseph; Wu, Foon; Modesti, Nidia; Nelson, Jay; Gaynor, Richard.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 87, No. 13, 1990, p. 5079-5083.

Research output: Contribution to journalArticle

@article{df52115664bb4bb58cf42768cdb18656,
title = "A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat",
abstract = "Regulation of human immunodeficiency virus (HIV) gene expression is dependent on specific regulatory region in the long terminal repeat. These regions include the enhancer, SP1, {"}TATA,{"} and trans-activating (TAR) regions, In addition, viral regulatory proteins such as tat and rev are Important in regulating HIV gene expression. The mechanism of tat activation remains the subject of investigation, but effects at both transcriptional and posttranscriptional levels seem likely. Pervious mutagenesis of the tat protein revealed that the amino terminus, the cysteine-rich domain, and the basic domain were all required for complete tat activation. Mutants of other viral trans-acting regulatory proteins, including E1A, tax, and VM65, have been identified that were capable of antagonizing the activity of their corresponding wild-type proteins. We wished to determine whether mutants of the tat protein could be identified that exhibited a similar phenotype. One mutant (Δ) that truncated the basic domain of tat resulted in a transdominant phenotype inhibiting tat-induced gene expression of the HIV long terminal repeat but not other viral promoters. This tant exhibited its maximal phenotype in cotransfection expriments when present in an 8- to 30-fold molar excess over the wild-type tat gene. Trans-activation of the HIV long terminal repeat by Δtat was very defective at the DNA concentrations in these experiments. RNase protection analysis indicated t this mutant decreased tat-induced steady-state mRNA levels of the HIV long terminal repeat. Second-site mutations of the gene in either the amino terminus or cysteine region lnated the transdominant phenotype. In contrast to tat, which was localized predominantly to the nucleolus, Δtat was present in both the nucleus and cytoplasm, suggesting that it may bit tat function by preventing nucleolar localization. Trans-dominant mutants of tat may have a role in potentially inhibiting HIV gene expression.",
author = "Low Pearson and Joseph Garcia and Foon Wu and Nidia Modesti and Jay Nelson and Richard Gaynor",
year = "1990",
language = "English (US)",
volume = "87",
pages = "5079--5083",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "13",

}

TY - JOUR

T1 - A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat

AU - Pearson, Low

AU - Garcia, Joseph

AU - Wu, Foon

AU - Modesti, Nidia

AU - Nelson, Jay

AU - Gaynor, Richard

PY - 1990

Y1 - 1990

N2 - Regulation of human immunodeficiency virus (HIV) gene expression is dependent on specific regulatory region in the long terminal repeat. These regions include the enhancer, SP1, "TATA," and trans-activating (TAR) regions, In addition, viral regulatory proteins such as tat and rev are Important in regulating HIV gene expression. The mechanism of tat activation remains the subject of investigation, but effects at both transcriptional and posttranscriptional levels seem likely. Pervious mutagenesis of the tat protein revealed that the amino terminus, the cysteine-rich domain, and the basic domain were all required for complete tat activation. Mutants of other viral trans-acting regulatory proteins, including E1A, tax, and VM65, have been identified that were capable of antagonizing the activity of their corresponding wild-type proteins. We wished to determine whether mutants of the tat protein could be identified that exhibited a similar phenotype. One mutant (Δ) that truncated the basic domain of tat resulted in a transdominant phenotype inhibiting tat-induced gene expression of the HIV long terminal repeat but not other viral promoters. This tant exhibited its maximal phenotype in cotransfection expriments when present in an 8- to 30-fold molar excess over the wild-type tat gene. Trans-activation of the HIV long terminal repeat by Δtat was very defective at the DNA concentrations in these experiments. RNase protection analysis indicated t this mutant decreased tat-induced steady-state mRNA levels of the HIV long terminal repeat. Second-site mutations of the gene in either the amino terminus or cysteine region lnated the transdominant phenotype. In contrast to tat, which was localized predominantly to the nucleolus, Δtat was present in both the nucleus and cytoplasm, suggesting that it may bit tat function by preventing nucleolar localization. Trans-dominant mutants of tat may have a role in potentially inhibiting HIV gene expression.

AB - Regulation of human immunodeficiency virus (HIV) gene expression is dependent on specific regulatory region in the long terminal repeat. These regions include the enhancer, SP1, "TATA," and trans-activating (TAR) regions, In addition, viral regulatory proteins such as tat and rev are Important in regulating HIV gene expression. The mechanism of tat activation remains the subject of investigation, but effects at both transcriptional and posttranscriptional levels seem likely. Pervious mutagenesis of the tat protein revealed that the amino terminus, the cysteine-rich domain, and the basic domain were all required for complete tat activation. Mutants of other viral trans-acting regulatory proteins, including E1A, tax, and VM65, have been identified that were capable of antagonizing the activity of their corresponding wild-type proteins. We wished to determine whether mutants of the tat protein could be identified that exhibited a similar phenotype. One mutant (Δ) that truncated the basic domain of tat resulted in a transdominant phenotype inhibiting tat-induced gene expression of the HIV long terminal repeat but not other viral promoters. This tant exhibited its maximal phenotype in cotransfection expriments when present in an 8- to 30-fold molar excess over the wild-type tat gene. Trans-activation of the HIV long terminal repeat by Δtat was very defective at the DNA concentrations in these experiments. RNase protection analysis indicated t this mutant decreased tat-induced steady-state mRNA levels of the HIV long terminal repeat. Second-site mutations of the gene in either the amino terminus or cysteine region lnated the transdominant phenotype. In contrast to tat, which was localized predominantly to the nucleolus, Δtat was present in both the nucleus and cytoplasm, suggesting that it may bit tat function by preventing nucleolar localization. Trans-dominant mutants of tat may have a role in potentially inhibiting HIV gene expression.

UR - http://www.scopus.com/inward/record.url?scp=0025324686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025324686&partnerID=8YFLogxK

M3 - Article

VL - 87

SP - 5079

EP - 5083

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 13

ER -